Welcome to the corner office! Each month, we’ll turn to a new panel of biopharma executives for insights about leadership and management — and tips for thriving in a roller-coaster industry. To share your views in future columns, please fill out this short form. To suggest questions for our panelists, email STAT Plus Editor Liz Cooney. This month, we asked:
What do you consider the toughest part of leadership?
Nima Farzan, president and CEO, PaxVax, Redwood City, Calif.
For me, it’s ensuring all of our talent is aligned and working together toward the same goal. One strategy that’s been very successful for us is having people spend time in other roles, even if only for a brief time. When our R&D leader spends the day in the field visiting customers, or the head of marketing is asked what production scheduling should look like, they’re able to understand each other’s challenges in a more tangible way and remain focused on what’s necessary for all of us to meet our goals.
This article is exclusive to STAT+ subscribers
Unlock this article — plus in-depth analysis, newsletters, premium events, and networking platform access.
Already have an account? Log in
Already have an account? Log in
To submit a correction request, please visit our Contact Us page.
STAT encourages you to share your voice. We welcome your commentary, criticism, and expertise on our subscriber-only platform, STAT+ Connect